Gradually , attention is developing within the UK regarding the drug as a viable solution for metabolic complications. While largely emerging , awareness of its potential benefits – particularly in managing the symptoms of HIV-related lipodystrophy – is gaining. Clinicians are researching its application , and patient inquiries is increasing ,